Leadership Team
The PsychoGenics team has a deep bench of highly trained experts with diverse skill sets. From our dedicated, proficient Ph.D. scientists from around the world to our veteran executives, every specialist on our team is dedicated to our client’s success. We are the preclinical partner you’ve been searching for.
Management Team
Emer Leahy, Ph.D., MBA
President and CEO
Mark Varney, Ph.D.
Chief Scientific Officer
Dani Brunner, Ph.D.
Chief Innovation Officer, Chief Technology Officer
Taleen Hanania, Ph.D.
Chief Commercial Officer
Sylvie Ramboz
Sr. VP, Behavioral Pharmacology
Afshin Ghavami, Ph.D.
VP, Research Operations
Stephen Morairty, Ph.D.
VP, Translational Neuroscience
Leslie Street, Ph.D.
VP, Medicinal Chemistry
Christina Leahy
Sr. VP, QA and Regulatory Affairs
Kathleen Kelly
VP, Human Resources
David Bleakman, Ph.D.
President, Drug Discovery and Development